1[1]Fetsch PA,Abati A,Hijazi YM.Utility of the antibodies CA19-9,HBME-1,and thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytology[J].Cancer, 1998,84:101-108.
2[2]Ko EC,Jhala NC,Shultz JJ,et al. Use of a panel of markers in the differential diagnosis of adenocarcinoma and reactive mesothelial cells in fluid cytology[J].Am J Clin Pathol,2001,116:709-715.
3[3]Fetsch PA,Simsir A,Abati A.Comparison of antibodies to HBME-1 and calretinin of mesothelial cells in effusion cytology[J].Diag Cytopathol,2001,25:158-161.
4[4]Simsir A,Fetsch P, Mehta D,et al.E-cadherin,N-cadherin and calretinin in pleural effusions:the good,the bad,the worthless[J].Diag Cytopathol, 1999,20:125-130.
5[5]Chhieng DC,Yee H,Cangiarella JF,et al. Use of E-cadherin and CD44 aids in the differentiation between reactive mesothelial cells and carcinoma cells in pelvic washings[J].Cancer,2000,90(5):299-304.
6[6]Afify AM,Al-Khafaji BM.Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids[J].Acta Cytol.2002,46:675-678.
7[7]Jang KY,Kang MJ,Lee DG,et al. Utility of thyroid transcription factor-1 and cytokeratin 7 and cytokeratin 20 immunostaining in the identification of origin in malignant effusions[J].Anal Quant Cytol Histol,2001,23:400-404.
8[8]Hecht JL, Pinkus JL, Weinstein LJ,et al.The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin[J].Am J Clin Pathol,2001,116:483-488.
9[9]Blumenfeld W,Turi GK,Harrison G,et al. Utility of cytokeratin 7 and 20 subset analysis an aid in the identification of primary site of origin of malignancy in cytologic specimens[J].Diag Cytopathol, 1999,20:63-66.
10[10]Davidson B,Risberg B,Kristensen G.Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers[J].Virchows Arch, 1999,435:43-49.
